New neuroprotective derivatives of cinnamic acid by biotransformation

Microbial transformation is extensively utilized to generate new metabolites in bulk amounts with more specificity and improved activity. As cinnamic acid was reported to exhibit several important pharmacological properties, microbial transformation was used to obtain its new derivatives with enhanced biological activities. By manipulating the 2-stage fermentation protocol of biotransformation, five metabolites were produced from cinnamic acid. Two of them were new derivatives; N -propyl cinnamamide 2&cmb.b.line; and 2-methyl heptyl benzoate 3&cmb.b.line; produced by Alternaria alternata . The other 3 metabolites, p -hydroxy benzoic acid 4&cmb.b.line; , cinnamyl alcohol 5&cmb.b.line; and methyl cinnamate 6&cmb.b.line; , were produced by Rhodotorula rubra , Rhizopus species and Penicillium chrysogeneum , respectively. Cinnamic acid and its metabolites were evaluated for their cyclooxygenase (COX) and acetylcholinesterase (AChE) inhibitory activities. Protection against H 2 O 2 and Aβ 1-42 induced-neurotoxicity in human neuroblastoma (SH-SY5Y) cells was also monitored. Metabolite 4&cmb.b.line; was more potent as a COX-2 inhibitor than the parent compound with an IC 50 value of 1.85 ± 0.07 μM. Out of the tested compounds, only metabolite 2&cmb.b.line; showed AChE inhibitory activity with an IC 50 value of 8.27 μM. These results were further correlated with an in silico study of the binding interactions of the active metabolites with the active sites of the studied enzymes. Metabolite 3&cmb.b.line; was more potent as a neuroprotective agent against H 2 O 2 and Aβ 1-42 induced-neurotoxicity than catechin and epigallocatechin-3-gallate as positive controls. This study suggested the two new metabolites 2&cmb.b.line; and 3&cmb.b.line; along with metabolite 4&cmb.b.line; as potential leads for neurodegenerative diseases associated with cholinergic deficiency, neurotoxicity or neuroinflammation. Microbial transformation is extensively utilized to generate new metabolites in bulk amounts with more specificity and improved activity.